{"id":51147,"date":"2022-11-22T18:03:12","date_gmt":"2022-11-22T17:03:12","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/median-technologies-to-speak-at-the-radiological-society-of-north-america-rsna-2022-annual-meeting-nov-27-dec-1-chicago-il-usa-with-three-presentations\/"},"modified":"2022-11-22T18:03:12","modified_gmt":"2022-11-22T17:03:12","slug":"median-technologies-to-speak-at-the-radiological-society-of-north-america-rsna-2022-annual-meeting-nov-27-dec-1-chicago-il-usa-with-three-presentations","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/median-technologies-to-speak-at-the-radiological-society-of-north-america-rsna-2022-annual-meeting-nov-27-dec-1-chicago-il-usa-with-three-presentations\/","title":{"rendered":"Median Technologies to Speak at the Radiological Society of North America (RSNA) 2022 Annual Meeting, Nov. 27 &#8211; Dec 1, Chicago, IL, USA, With Three Presentations"},"content":{"rendered":"<div>\n<ul class=\"bwlistdisc\">\n<li>\nAI Showcase Theater Presentation: \u201cEnabling Lung Cancer Screening with iBiopsy\u00ae AI-based Software as Medical Device\u201d\n<\/li>\n<li>\nScientific Presentation: \u201dDevelopment of an AI\/ML Tech Based Pulmonary Nodule Malignancy Prediction Model: Application to Indeterminate Pulmonary Nodules and Early-Stage Cancers\u201d\n<\/li>\n<li>\nVirtual Poster Presentation: \u201cDiscordance rates on primary tumor assessment between Blinded Independent Central Review (BICR) readers in advanced or metastatic esophageal cancer applying RECIST 1.1 criteria\u201d\n<\/li>\n<li>\nMedian\u2019s teams will be at booth #4849 AI showcase, to present the latest developments on iBiopsy\u00ae as well as its imaging CRO offering.\n<\/li>\n<\/ul>\n<p>SOPHIA ANTIPOLIS, France&#8211;(BUSINESS WIRE)&#8211;Regulatory News:\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20221122005416\/en\/1343975\/5\/Median_RGB.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20221122005416\/en\/1343975\/21\/Median_RGB.jpg\"><\/a><\/p>\n<p>\nMedian Technologies (ALMDT) (Paris:ALMDT) announced today that the Company will be speaking and presenting at the world\u2019s largest medical imaging conference, the 2022 Radiological Society of North America (RSNA) Annual Meeting and Scientific Assembly, being held in Chicago, IL, USA, Nov. 27 \u2013 Dec. 1.\n<\/p>\n<p>\nThe Company will give an industry presentation and two scientific presentations. Details of the sessions include:\n<\/p>\n<p>\n<b><a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fconnect.myesr.org%2Fecr-2022%2Fecr-2022-programme%2F%3Ftabref%3D1&amp;esheet=52976344&amp;newsitemid=20221122005416&amp;lan=en-US&amp;anchor=Industry+presentation%3A&amp;index=1&amp;md5=a347ab192eb4428d89b5ef51882adcc3\" rel=\"nofollow noopener\" shape=\"rect\">Industry presentation:<\/a><\/b> \u201c<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Feppro02.ativ.me%2Fweb%2Fplanner.php%3Fid%3DRSNA22%26tabid%3D8&amp;esheet=52976344&amp;newsitemid=20221122005416&amp;lan=en-US&amp;anchor=Enabling+lung+cancer+screening+with+iBiopsy%26%23174%3B+AI-based+software+as+medical+device&amp;index=2&amp;md5=e64a1cd2fb97382a4136e8aafb826fa2\" rel=\"nofollow noopener\" shape=\"rect\">Enabling lung cancer screening with iBiopsy\u00ae AI-based software as medical device<\/a>\u201d\n<\/p>\n<p class=\"bwmarginl1\">\nSession: AI Showcase Theater<br \/>\n<br \/>Date: November 27, 2022<br \/>\n<br \/>Time: 11:30 am \u2013 11:45 am CST<br \/>\n<br \/>Place: South Hall Level 3, AI showcase theater\n<\/p>\n<p>\n<b>Virtual Poster Presentation<\/b>: <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Feppro02.ativ.me%2Fweb%2Fplanner.php%3Fid%3DRSNA22%26tabid%3D2&amp;esheet=52976344&amp;newsitemid=20221122005416&amp;lan=en-US&amp;anchor=%26%238220%3BDiscordance+rates+on+primary+tumor+assessment+between+Blinded+Independent+Central+Review+%28BICR%29+readers+in+advanced+or+metastatic+esophageal+cancer+applying+RECIST+1.1+criteria%26%238221%3B&amp;index=3&amp;md5=6bc93fb8eb671a34666f1ddd9d079e15\" rel=\"nofollow noopener\" shape=\"rect\">\u201cDiscordance rates on primary tumor assessment between Blinded Independent Central Review (BICR) readers in advanced or metastatic esophageal cancer applying RECIST 1.1 criteria\u201d<\/a>\n<\/p>\n<p class=\"bwmarginl1\">\nSession Number: W5B-SPGI<br \/>\n<br \/>Date: November 30, 2022<br \/>\n<br \/>Time: 12:45 pm &#8211; 1:15 pm CST<br \/>\n<br \/>Place: East Level 3, Learning Center \u2013 GI DPS\n<\/p>\n<p>\n<b>Scientific Presentation: <\/b><a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Feppro02.ativ.me%2Fweb%2Fplanner.php%3Fid%3DRSNA22%26tabid%3D2&amp;esheet=52976344&amp;newsitemid=20221122005416&amp;lan=en-US&amp;anchor=%26%238221%3BDevelopment+of+an+AI%2FML+Tech+Based+Pulmonary+Nodule+Malignancy+Prediction+Model%3A+Application+to+Indeterminate+Pulmonary+Nodules+and+Early-Stage+Cancers%26%238221%3B&amp;index=4&amp;md5=340f2c2aec20b203e203a23523d5150a\" rel=\"nofollow noopener\" shape=\"rect\">\u201dDevelopment of an AI\/ML Tech Based Pulmonary Nodule Malignancy Prediction Model: Application to Indeterminate Pulmonary Nodules and Early-Stage Cancers\u201d<\/a>\n<\/p>\n<p class=\"bwmarginl1\">\nSession Number: W7-SSIN06-1<br \/>\n<br \/>Date: November 30, 2022<br \/>\n<br \/>Time: 3.00 pm &#8211; 4.00 pm CST<br \/>\n<br \/>Place: South Level 4, S404\n<\/p>\n<p>\nMedian\u2019s teams will be available at booth #4849, Level 3 South Hall (AI showcase) for the duration of the industry exhibition (Nov 27- 30).\n<\/p>\n<p>\n<b>About Median Technologies:<\/b> Median Technologies provides innovative imaging solutions and services to advance healthcare for everyone. We harness the power of medical images by using the most advanced Artificial Intelligence technologies, to increase the accuracy of diagnosis and treatment of many cancers and other metabolic diseases at their earliest stages and provide insights into novel therapies for patients. Our iCRO solutions for medical image analysis and management in oncology trials and iBiopsy\u00ae, our AI-powered software as medical device help biopharmaceutical companies and clinicians to bring new treatments and diagnose patients earlier and more accurately. This is how we are helping to create a healthier world.\n<\/p>\n<p>\nFounded in 2002, based in Sophia-Antipolis, France, with a subsidiary in the US and another one in Shanghai, Median has received the label \u201cInnovative company\u201d by the BPI and is listed on Euronext Growth market (Paris). FR0011049824\u2013 ticker: ALMDT. Median is eligible for the French SME equity savings plan scheme (PEA-PME), is part of the Enternext\u00ae PEA-PME 150 index and has been awarded the Euronext European Rising Tech label. For more information: <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.mediantechnologies.com%2F&amp;esheet=52976344&amp;newsitemid=20221122005416&amp;lan=en-US&amp;anchor=www.mediantechnologies.com&amp;index=5&amp;md5=abd37e042502f23eac4b4c67baac9e75\" rel=\"nofollow noopener\" shape=\"rect\">www.mediantechnologies.com<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nMedian Technologies<br \/>\n<br \/>Emmanuelle Leygues<br \/>\n<br \/>Head of Corporate Marketing &amp; Financial Communications<br \/>\n<br \/>+33 6 10 93 58 88<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#x69;&#x6c;&#x74;&#x6f;&#x3a;&#x65;&#x6d;&#x6d;&#x61;&#x6e;&#x75;&#x65;&#x6c;&#x6c;&#x65;&#x2e;&#x6c;&#x65;&#x79;&#x67;&#117;&#101;&#115;&#64;&#109;&#101;&#100;&#105;&#97;&#110;&#116;&#101;&#99;&#104;&#110;ologies&#46;com\" rel=\"nofollow noopener\" shape=\"rect\">&#x65;&#x6d;&#109;&#97;n&#x75;&#x65;&#x6c;&#108;e&#46;&#x6c;&#x65;&#121;&#103;u&#x65;&#x73;&#x40;&#109;ed&#x69;&#x61;&#110;&#116;e&#x63;&#x68;&#x6e;&#111;lo&#x67;&#x69;&#101;&#115;&#46;&#x63;&#x6f;&#x6d;<\/a>\n<\/p>\n<p>\nPress &#8211; ALIZE RP<br \/>\n<br \/>Caroline Carmagnol<br \/>\n<br \/>+33 6 64 18 99 59<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;i&#108;&#x74;o&#58;&#x6d;e&#100;&#x69;a&#110;&#x40;a&#108;&#x69;z&#101;&#x72;p&#46;&#x63;o&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#109;&#x65;&#100;&#x69;a&#x6e;&#64;&#97;&#x6c;&#105;&#x7a;e&#x72;p&#46;&#x63;&#111;&#x6d;<\/a>\n<\/p>\n<p>\nInvestors &#8211; ACTIFIN<br \/>\n<br \/>Ghislaine Gasparetto<br \/>\n<br \/>+33 6 21 10 49 24<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;i&#108;&#x74;&#111;&#x3a;g&#103;&#x61;s&#x70;&#x61;&#114;&#x65;t&#116;&#x6f;&#64;&#x61;&#x63;&#116;&#x69;f&#105;&#x6e;&#46;&#x66;r\" rel=\"nofollow noopener\" shape=\"rect\">gga&#115;&#112;&#97;&#114;&#x65;&#x74;&#x74;&#x6f;&#x40;&#x61;&#x63;tif&#105;&#110;&#46;&#102;&#114;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>AI Showcase Theater Presentation: \u201cEnabling Lung Cancer Screening with iBiopsy\u00ae AI-based Software as Medical Device\u201d Scientific Presentation: \u201dDevelopment of an AI\/ML Tech Based Pulmonary Nodule Malignancy Prediction Model: Application to Indeterminate Pulmonary Nodules and Early-Stage Cancers\u201d Virtual Poster Presentation: \u201cDiscordance rates on primary tumor assessment between Blinded Independent Central Review (BICR) readers in advanced or &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/median-technologies-to-speak-at-the-radiological-society-of-north-america-rsna-2022-annual-meeting-nov-27-dec-1-chicago-il-usa-with-three-presentations\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-51147","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Median Technologies to Speak at the Radiological Society of North America (RSNA) 2022 Annual Meeting, Nov. 27 - Dec 1, Chicago, IL, USA, With Three Presentations - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/median-technologies-to-speak-at-the-radiological-society-of-north-america-rsna-2022-annual-meeting-nov-27-dec-1-chicago-il-usa-with-three-presentations\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Median Technologies to Speak at the Radiological Society of North America (RSNA) 2022 Annual Meeting, Nov. 27 - Dec 1, Chicago, IL, USA, With Three Presentations - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"AI Showcase Theater Presentation: \u201cEnabling Lung Cancer Screening with iBiopsy\u00ae AI-based Software as Medical Device\u201d Scientific Presentation: \u201dDevelopment of an AI\/ML Tech Based Pulmonary Nodule Malignancy Prediction Model: Application to Indeterminate Pulmonary Nodules and Early-Stage Cancers\u201d Virtual Poster Presentation: \u201cDiscordance rates on primary tumor assessment between Blinded Independent Central Review (BICR) readers in advanced or ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/median-technologies-to-speak-at-the-radiological-society-of-north-america-rsna-2022-annual-meeting-nov-27-dec-1-chicago-il-usa-with-three-presentations\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-22T17:03:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221122005416\/en\/1343975\/21\/Median_RGB.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/median-technologies-to-speak-at-the-radiological-society-of-north-america-rsna-2022-annual-meeting-nov-27-dec-1-chicago-il-usa-with-three-presentations\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/median-technologies-to-speak-at-the-radiological-society-of-north-america-rsna-2022-annual-meeting-nov-27-dec-1-chicago-il-usa-with-three-presentations\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Median Technologies to Speak at the Radiological Society of North America (RSNA) 2022 Annual Meeting, Nov. 27 &#8211; Dec 1, Chicago, IL, USA, With Three Presentations\",\"datePublished\":\"2022-11-22T17:03:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/median-technologies-to-speak-at-the-radiological-society-of-north-america-rsna-2022-annual-meeting-nov-27-dec-1-chicago-il-usa-with-three-presentations\\\/\"},\"wordCount\":518,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/median-technologies-to-speak-at-the-radiological-society-of-north-america-rsna-2022-annual-meeting-nov-27-dec-1-chicago-il-usa-with-three-presentations\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221122005416\\\/en\\\/1343975\\\/21\\\/Median_RGB.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/median-technologies-to-speak-at-the-radiological-society-of-north-america-rsna-2022-annual-meeting-nov-27-dec-1-chicago-il-usa-with-three-presentations\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/median-technologies-to-speak-at-the-radiological-society-of-north-america-rsna-2022-annual-meeting-nov-27-dec-1-chicago-il-usa-with-three-presentations\\\/\",\"name\":\"Median Technologies to Speak at the Radiological Society of North America (RSNA) 2022 Annual Meeting, Nov. 27 - Dec 1, Chicago, IL, USA, With Three Presentations - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/median-technologies-to-speak-at-the-radiological-society-of-north-america-rsna-2022-annual-meeting-nov-27-dec-1-chicago-il-usa-with-three-presentations\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/median-technologies-to-speak-at-the-radiological-society-of-north-america-rsna-2022-annual-meeting-nov-27-dec-1-chicago-il-usa-with-three-presentations\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221122005416\\\/en\\\/1343975\\\/21\\\/Median_RGB.jpg\",\"datePublished\":\"2022-11-22T17:03:12+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/median-technologies-to-speak-at-the-radiological-society-of-north-america-rsna-2022-annual-meeting-nov-27-dec-1-chicago-il-usa-with-three-presentations\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/median-technologies-to-speak-at-the-radiological-society-of-north-america-rsna-2022-annual-meeting-nov-27-dec-1-chicago-il-usa-with-three-presentations\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/median-technologies-to-speak-at-the-radiological-society-of-north-america-rsna-2022-annual-meeting-nov-27-dec-1-chicago-il-usa-with-three-presentations\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221122005416\\\/en\\\/1343975\\\/21\\\/Median_RGB.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221122005416\\\/en\\\/1343975\\\/21\\\/Median_RGB.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/median-technologies-to-speak-at-the-radiological-society-of-north-america-rsna-2022-annual-meeting-nov-27-dec-1-chicago-il-usa-with-three-presentations\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Median Technologies to Speak at the Radiological Society of North America (RSNA) 2022 Annual Meeting, Nov. 27 &#8211; Dec 1, Chicago, IL, USA, With Three Presentations\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Median Technologies to Speak at the Radiological Society of North America (RSNA) 2022 Annual Meeting, Nov. 27 - Dec 1, Chicago, IL, USA, With Three Presentations - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/median-technologies-to-speak-at-the-radiological-society-of-north-america-rsna-2022-annual-meeting-nov-27-dec-1-chicago-il-usa-with-three-presentations\/","og_locale":"en_US","og_type":"article","og_title":"Median Technologies to Speak at the Radiological Society of North America (RSNA) 2022 Annual Meeting, Nov. 27 - Dec 1, Chicago, IL, USA, With Three Presentations - Pharma Trend","og_description":"AI Showcase Theater Presentation: \u201cEnabling Lung Cancer Screening with iBiopsy\u00ae AI-based Software as Medical Device\u201d Scientific Presentation: \u201dDevelopment of an AI\/ML Tech Based Pulmonary Nodule Malignancy Prediction Model: Application to Indeterminate Pulmonary Nodules and Early-Stage Cancers\u201d Virtual Poster Presentation: \u201cDiscordance rates on primary tumor assessment between Blinded Independent Central Review (BICR) readers in advanced or ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/median-technologies-to-speak-at-the-radiological-society-of-north-america-rsna-2022-annual-meeting-nov-27-dec-1-chicago-il-usa-with-three-presentations\/","og_site_name":"Pharma Trend","article_published_time":"2022-11-22T17:03:12+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221122005416\/en\/1343975\/21\/Median_RGB.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/median-technologies-to-speak-at-the-radiological-society-of-north-america-rsna-2022-annual-meeting-nov-27-dec-1-chicago-il-usa-with-three-presentations\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/median-technologies-to-speak-at-the-radiological-society-of-north-america-rsna-2022-annual-meeting-nov-27-dec-1-chicago-il-usa-with-three-presentations\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Median Technologies to Speak at the Radiological Society of North America (RSNA) 2022 Annual Meeting, Nov. 27 &#8211; Dec 1, Chicago, IL, USA, With Three Presentations","datePublished":"2022-11-22T17:03:12+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/median-technologies-to-speak-at-the-radiological-society-of-north-america-rsna-2022-annual-meeting-nov-27-dec-1-chicago-il-usa-with-three-presentations\/"},"wordCount":518,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/median-technologies-to-speak-at-the-radiological-society-of-north-america-rsna-2022-annual-meeting-nov-27-dec-1-chicago-il-usa-with-three-presentations\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221122005416\/en\/1343975\/21\/Median_RGB.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/median-technologies-to-speak-at-the-radiological-society-of-north-america-rsna-2022-annual-meeting-nov-27-dec-1-chicago-il-usa-with-three-presentations\/","url":"https:\/\/pharma-trend.com\/en\/median-technologies-to-speak-at-the-radiological-society-of-north-america-rsna-2022-annual-meeting-nov-27-dec-1-chicago-il-usa-with-three-presentations\/","name":"Median Technologies to Speak at the Radiological Society of North America (RSNA) 2022 Annual Meeting, Nov. 27 - Dec 1, Chicago, IL, USA, With Three Presentations - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/median-technologies-to-speak-at-the-radiological-society-of-north-america-rsna-2022-annual-meeting-nov-27-dec-1-chicago-il-usa-with-three-presentations\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/median-technologies-to-speak-at-the-radiological-society-of-north-america-rsna-2022-annual-meeting-nov-27-dec-1-chicago-il-usa-with-three-presentations\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221122005416\/en\/1343975\/21\/Median_RGB.jpg","datePublished":"2022-11-22T17:03:12+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/median-technologies-to-speak-at-the-radiological-society-of-north-america-rsna-2022-annual-meeting-nov-27-dec-1-chicago-il-usa-with-three-presentations\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/median-technologies-to-speak-at-the-radiological-society-of-north-america-rsna-2022-annual-meeting-nov-27-dec-1-chicago-il-usa-with-three-presentations\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/median-technologies-to-speak-at-the-radiological-society-of-north-america-rsna-2022-annual-meeting-nov-27-dec-1-chicago-il-usa-with-three-presentations\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221122005416\/en\/1343975\/21\/Median_RGB.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221122005416\/en\/1343975\/21\/Median_RGB.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/median-technologies-to-speak-at-the-radiological-society-of-north-america-rsna-2022-annual-meeting-nov-27-dec-1-chicago-il-usa-with-three-presentations\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Median Technologies to Speak at the Radiological Society of North America (RSNA) 2022 Annual Meeting, Nov. 27 &#8211; Dec 1, Chicago, IL, USA, With Three Presentations"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/51147","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=51147"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/51147\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=51147"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=51147"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=51147"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}